Paranasal sinus disorder
MONDO:0001735A disease involving the paranasal sinus.
Also known as: disease of paranasal sinus, disease or disorder of paranasal sinus, disorder of paranasal sinus, paranasal sinus disease, paranasal sinus disease or disorder, paranasal sinus disorder, sinus disorder
162 clinical trials for this condition and its sub-types, 12 tagged with Paranasal sinus disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Paranasal sinus disorder
-
Sinusitis 44 trials · 130 incl. sub-types
5 sub-types
- Chronic rhinosinusitis 89 trials · 91 incl. sub-types Sub-types →
- Maxillary sinusitis 5 trials · 7 incl. sub-types Sub-types →
- Frontal sinusitis 2 trials Sub-types →
- Ethmoid sinusitis 0 trials Sub-types →
- Sphenoid sinusitis 0 trials Sub-types →
-
Paranasal sinus neoplasm 5 trials · 29 incl. sub-types
6 sub-types
- Paranasal sinus cancer 4 trials · 24 incl. sub-types Sub-types →
- Maxillary sinus neoplasm 1 trial · 2 incl. sub-types Sub-types →
- Ethmoidal sinus neoplasm 0 trials Sub-types →
- Frontal sinus neoplasm 0 trials Sub-types →
- Paranasal sinus Schneiderian papilloma 0 trials Sub-types →
- Sphenoidal sinus neoplasm 0 trials Sub-types →
-
Maxillary sinus cholesteatoma 0 trials
-
Polyp of ethmoidal sinus 0 trials
-
Polyp of frontal sinus 0 trials
-
Polyp of maxillary sinus 0 trials
-
Polyp of sphenoidal sinus 0 trials
Most studied deeper sub-types
-
Can an antibody injection shrink nasal polyps?
Disease control CompletedResearchers are testing an experimental antibody drug called verekitug in adults with chronic rhinosinusitis with nasal polyps, a condition where inflamed tissue grows inside the nasal passages and causes congestion. Participants receive either verekitug or a placebo injection wh…
Phase 2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a drug that calms inflammation ease chronic sinusitis?
Disease control CompletedThis trial tests whether dupilumab, an injectable drug that blocks certain inflammatory signals, can reduce sinus swelling and improve symptoms like loss of smell and runny nose in adults with chronic sinusitis who do not have nasal polyps. Participants receive either dupilumab o…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a drug shrink nasal polyps in rare disease patients?
Symptom relief CompletedThis study looked at 52 adults with EGPA (a rare inflammatory disease) and severe chronic sinusitis with nasal polyps. They received mepolizumab 300 mg every 4 weeks. The goal was to see if the drug reduces polyp size and improves symptoms like nasal congestion and sense of smell…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC